A szöveti angiotenzinkonvertáló enzim szerepe a cardiovascularis betegségekben

Translated title of the contribution: Role of tissue angiotensin converting enzyme in cardiovascular diseases

Mohácsi Attila, Lizanecz Erzsébet, Édes István, Czuriga István

Research output: Contribution to journalArticle

Abstract

The pathobiological aim of treatment with angiotensin converting enzyme inhibitor is to restore the balance between nitrogen-monoxide and angiotensin II due to inhibition of blood and tissue angiotensin converting enzyme. The clinical consquences of the inhibition of tissue angiotensin converting enzyme in patients with additionally high (HOPE) and low (EUROPA) cardiovascular risk without left ventricular dysfunction has already been demonstrated. Ramipril and the perindopril reduce the risk of combined end-point of these trials such as cardiovascular mortality, reinfarction and resuscitated sudden cardiac death. However, pharmacological and genetic differences in blocking of tissue angiotensin converting enzyme may influence the cardioprotective effect of various angiotensin converting enzyme inhibitors. Thus new, well-designed, controlled clinical trials are needed to determine the role of angiotensin converting enzyme inhibitor with different tissue angiotensin converting enzyme affinity in cardiovascular disease.

Translated title of the contributionRole of tissue angiotensin converting enzyme in cardiovascular diseases
Original languageHungarian
Pages (from-to)843-849
Number of pages7
JournalLege Artis Medicinae
Volume14
Issue number12
Publication statusPublished - Dec 1 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Role of tissue angiotensin converting enzyme in cardiovascular diseases'. Together they form a unique fingerprint.

  • Cite this